Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 124

1.

Hepatitis C virus and natural compounds: a new antiviral approach?

Calland N, Dubuisson J, Rouillé Y, Séron K.

Viruses. 2012 Oct 17;4(10):2197-217. doi: 10.3390/v4102197. Review.

PMID:
23202460
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

New targets for antiviral therapy of chronic hepatitis C.

Bühler S, Bartenschlager R.

Liver Int. 2012 Feb;32 Suppl 1:9-16. doi: 10.1111/j.1478-3231.2011.02701.x. Review.

PMID:
22212566
[PubMed - indexed for MEDLINE]
3.

[Antiviral treatment of chronic hepatitis C].

Berger A.

Med Monatsschr Pharm. 2012 Feb;35(2):55-60. Review. German.

PMID:
22400430
[PubMed - indexed for MEDLINE]
4.

Hepatitis C virus resistance to protease inhibitors.

Halfon P, Locarnini S.

J Hepatol. 2011 Jul;55(1):192-206. doi: 10.1016/j.jhep.2011.01.011. Epub 2011 Feb 1. Review.

PMID:
21284949
[PubMed - indexed for MEDLINE]
Free Article
5.

HCV's days are numbered: next-generation direct-acting antivirals and host-targeting agents.

Calle Serrano B, Manns MP.

Antivir Ther. 2012;17(6 Pt B):1133-46. doi: 10.3851/IMP2425. Epub 2012 Oct 5. Review.

PMID:
23188760
[PubMed - indexed for MEDLINE]
6.

Second generation direct antivirals and the way to interferon-free regimens in chronic HCV.

Lewis H, Cunningham M, Foster G.

Best Pract Res Clin Gastroenterol. 2012 Aug;26(4):471-85. doi: 10.1016/j.bpg.2012.09.008. Review.

PMID:
23199506
[PubMed - indexed for MEDLINE]
7.

[HCV entry as a new therapeutic target in chronic hepatitis C].

Dabrowska MM, Panasiuk A, Flisiak R.

Pol Merkur Lekarski. 2009 Aug;27(158):140-3. Review. Polish.

PMID:
19856882
[PubMed - indexed for MEDLINE]
8.

The science of direct-acting antiviral and host-targeted agent therapy.

Pawlotsky JM.

Antivir Ther. 2012;17(6 Pt B):1109-17. doi: 10.3851/IMP2423. Epub 2012 Oct 5. Review.

PMID:
23188746
[PubMed - indexed for MEDLINE]
9.

New NS5B polymerase inhibitors for hepatitis C.

Legrand-Abravanel F, Nicot F, Izopet J.

Expert Opin Investig Drugs. 2010 Aug;19(8):963-75. doi: 10.1517/13543784.2010.500285. Review.

PMID:
20629614
[PubMed - indexed for MEDLINE]
10.

Interferon stimulated genes and hepatitis C virus infection.

Asselah T.

J Interferon Cytokine Res. 2012 Dec;32(12):557-62. doi: 10.1089/jir.2012.0059. Epub 2012 Nov 14. Review.

PMID:
23151203
[PubMed - indexed for MEDLINE]
11.

Nucleoside analog inhibitors of hepatitis C viral replication: recent advances, challenges and trends.

Furman PA, Lam AM, Murakami E.

Future Med Chem. 2009 Nov;1(8):1429-52. doi: 10.4155/fmc.09.88. Review.

PMID:
21426058
[PubMed - indexed for MEDLINE]
12.

New direct-acting antivirals' combination for the treatment of chronic hepatitis C.

Asselah T, Marcellin P.

Liver Int. 2011 Jan;31 Suppl 1:68-77. doi: 10.1111/j.1478-3231.2010.02411.x. Review.

PMID:
21205141
[PubMed - indexed for MEDLINE]
13.

New advances in the molecular biology of hepatitis C virus infection: towards the identification of new treatment targets.

Ploss A, Dubuisson J.

Gut. 2012 May;61 Suppl 1:i25-35. doi: 10.1136/gutjnl-2012-302048. Review.

PMID:
22504917
[PubMed - indexed for MEDLINE]
14.

Antiviral resistance and direct-acting antiviral agents for HCV.

Aloia AL, Locarnini S, Beard MR.

Antivir Ther. 2012;17(6 Pt B):1147-62. doi: 10.3851/IMP2426. Epub 2012 Oct 5. Review.

PMID:
23188771
[PubMed - indexed for MEDLINE]
15.

(-)-Epigallocatechin-3-gallate is a new inhibitor of hepatitis C virus entry.

Calland N, Albecka A, Belouzard S, Wychowski C, Duverlie G, Descamps V, Hober D, Dubuisson J, Rouillé Y, Séron K.

Hepatology. 2012 Mar;55(3):720-9. doi: 10.1002/hep.24803.

PMID:
22105803
[PubMed - indexed for MEDLINE]
16.

Recent successes and noteworthy future prospects in the treatment of chronic hepatitis C.

Fox AN, Jacobson IM.

Clin Infect Dis. 2012 Jul;55 Suppl 1:S16-24. doi: 10.1093/cid/cis391.

PMID:
22715209
[PubMed - indexed for MEDLINE]
Free Article
17.

Selective inhibitors of hepatitis C virus replication.

Neyts J.

Antiviral Res. 2006 Sep;71(2-3):363-71. Epub 2006 Jun 23. Review.

PMID:
16843538
[PubMed - indexed for MEDLINE]
18.

Treating hepatitis C infection by targeting the host.

Salloum S, Tai AW.

Transl Res. 2012 Jun;159(6):421-9. doi: 10.1016/j.trsl.2011.12.007. Epub 2012 Jan 10. Review.

PMID:
22633094
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Mathematical modelling of HCV infection: what can it teach us in the era of direct-acting antiviral agents?

Chatterjee A, Guedj J, Perelson AS.

Antivir Ther. 2012;17(6 Pt B):1171-82. doi: 10.3851/IMP2428. Epub 2012 Oct 5. Review.

PMID:
23186606
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Hepatitis C virus experimental model systems and antiviral drug research.

Uprichard SL.

Virol Sin. 2010 Aug;25(4):227-45. doi: 10.1007/s12250-010-3134-0. Epub 2010 Jul 28. Review.

PMID:
20960298
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk